chevron_leftBack
As of 13 June 2026, Zhaoke Ophthalmology Ltd. has a market cap of $210.05M USD, ranking #20745 globally and #5717 in China.
It ranks #1863 in the Healthcare sector, and #677 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$210.05MUSD
1.65B HKD
Enterprise Value
$115.14MUSD
902.38M HKD
Revenue (TTM)
$4.54MUSD
35.58M HKD
EBITDA (TTM)
-$33.84MUSD
-265.25M HKD
Net Income (TTM)
-$29.67MUSD
-232.56M HKD
PS Ratio
46.3
PB Ratio
0.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Xiaoyi Li
open_in_new
Employees
276
Founded
2017
Website
zkoph.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -3.3% | -4.3% | -0.3% | -19% | -3.7% | 67% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
6622
兆科眼科有限公司
ISIN: KYG989M51017
Shares Out.:
Shares Outstanding:
548.749M1
Shares Float:
313.067M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
2.90 HKD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Zhaoke Ophthalmology Ltd.
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, Hong Kong, and internationally. It develops various drugs that cover ophthalmic indications, including dry eye disease, myopia, presbyopia, wet age-related macular degeneration, diabetic macular edema, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People’s Republic of China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
26K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
24K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
13K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
9K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
8K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
8K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
363K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
260K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
172K%
|
97.4
|
|
SIX: RO
|
$321.52B
153K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
137K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
131K%
218.9B CHF
|
20.5
|
chevron_leftBack